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Background: The use of edible plants is an integral part of dietary behavior in the West region of Cameroon.
Dorstenia psilurus (Moraceae) is widely used as spice and as medicinal plant for the treatment of several diseases in
Cameroon. The aim of this study is to investigate the cytotoxic and apoptotic potential of methanol extract of
D. psilurus in human promyelocytic leukemia (HL-60) cells and prostate cancer (PC-3) cells.
Methods: Cytotoxicity of D. psilurus extract was tested in HL-60 and PC-3 cells using 3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) reduction assay and flow cytometric methods
Results: The methanol extract of D. psilurus have significant in vitro cytotoxic activity in HL-60 cells and PC-3 cells
with IC50 value of 12 ±1.54 μg/ml and 18 ± 0.45 μg/ml respectively after 48 h. The mechanism of antiproliferative
activity showed that after 24 h, D. psilurus extract induces apoptosis on HL-60 cells by the generation of reactive
oxygen species (ROS) along with concurrent loss of mitochondrial membrane potential, modification in the DNA
distribution and enhance of G2/M phase cell cycle.
Conclusion: The extract induces apoptosis of HL-60 cells associated with ROS production, loss of mitochondrial
membrane potential and apoptotic DNA fragmentation.
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Spices have served humans as valuable components of
seasonings, medicines, and have played a significant role
in maintaining human health and improving the quality
of human life for thousands of years. There is no doubt
that increasing the intake of spices is one of the most ef-
fective, convenient and economical ways in which we
can fortify ourselves against infectious diseases and re-
lated cancers [1]. To date, hundreds of compounds have
been identified as potential remedies of cancer, several
of which are active ingredients in herbs and spices [2].* Correspondence: apieme@yahoo.fr; aksaxena@iiim.ac.in
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reproduction in any medium, provided the orThe use of herbal remedies based on spices as a kind of
complementary and alternative medicine (CAM) is doc-
umented in the population especially among cancer pa-
tients [3-5]. The spice based herbal medicines and the
constituents have been reported to inhibit the prolifera-
tion of cancer cells directly. In vitro studies indicate that
herbs, spices, and their bioactive components can in-
hibit, and sometimes induce pathways that regulate cell
division, cell proliferation, detoxification, in addition to
the inflammatory and immune response [2,6]. For in-
stance, ursolic acid, a bioactive component in some
herbs and spices, suppressed TNF-induced expression of
genes regulated by NF-κB (cyclin D1, COX-2, and
MMP-9) which are involved in tumor initiation, promo-
tion, and metastasis [7]. In Cameroon, several studiesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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spices on different cell lines [8-10].
Dorstenia psilurus (Moraceae) is a plant from widely
used in Cameroon, Africa and Madasgascar for different
purposes. Plant drugs from this genus have shown a
broader acceptability among some indigenous populations
[11,12]. The roots of D. psilurus are used in Cameroon as
spices in the traditional meal called “Nkui” and “Nah poh”.
It is also claimed to preserve health, prevent ageing, to im-
prove the wellbeing and freshness of young mothers after
several pregnancies. The chemical composition in terms of
macronutrients and micronutrients of roots extract
of D. psilurus has been reported [13]. A decoction of leaves
of D. psilurus is used in Cameroon to treat rheumatism,
snake bites, headache and stomach disorders, arthralgia,
cardiovascular disorders, diuretic, tonic, stimulant, anal-
gesic, inflammatory diseases and cancers [14,15]. Phyto-
chemical analysis of root extract of this plant demonstrated
the presence of prenylated flavonoids, stearyl-p-coumarate,
stearylferulate, benzofuran derivatives, Dorsilurins C, D and
E [16] and Dorsilurins (F-K) [17]. The methanol extract of
D. psilurus has been reported to have anti-inflammatory
property [12]. Some biological activities of root extract of
D. psilurus such as the scavenging property on DPPH rad-
ical [12], anti-amylase, anti-lipase and antioxidant activities
[18] and hypertensive effects, glucosidase inhibitors pro-
perty [17], antibacterial activity [19] and cytotoxicity activity
on MiaPaCa-2 (panceatic), CCRF-CEM, CEM/ADR5000
(leukemia) cells have been demonstrated [8].
However, there are no studies on the cytotoxicity or apop-
tosis inducing properties of the roots extracts of D. psilurus
on human promyelocytic leukemia (HL-60) and prostate
cancer (PC-3) cell lines. Therefore this research aimed to de-
termine the cytotoxic of the methanol extract of D. psilurus
(root) on two cell lines (HL-60 and PC-3) and investigate its
toxicological mechanism on the most sensitive cells.
Methods
Plant material and extraction
The roots of Dorstenia psilurus (D. psilurus) were col-
lected at Komako in the West Region of Cameroon and
identified by Mr Victor NANA, of the National Herbarium
of Cameroon, in December 2010. A voucher specimen
(1649/SRF/CAM) was deposited at the National Herbar-
ium Yaounde, Cameroon. The roots of D. psilurus (DP)
were air-dried and ground. The powdered plant material
(150 g) was macerated in MeOH (1 l) for 24 h at room
temperature and then repeated once. The diluted extract
was concentrated under reduced pressure to afford 40 g of
a dark residue.
Cell culture
Human promyelocytic leukemia (HL-60 cells) and prostate
cancer (PC-3 cells) were obtained from European Collectionof Cells Culture (ECCC), Sigma Aldrich, India. They were
grown in RPMI-1640 medium containing 10% Foetal bo-
vine serum (FBS), penicillin (100 IU/ml) and streptomycin
(100 μg/ml medium). The cells were culture in the incuba-
tor (Thermocom Electron Corporation, USA) at 37°C, 5%
CO2; 98% humidity. Cells were used for different assays
during logarithmic growth phase while the untreated con-
trol cultures received only the vehicle (DMSO <0.1%).
Cells viability and treatments
The human promyelocytic leukemia (HL-60 cells) and
prostate cancer (PC-3 cells) were seeded in different 96
well plates containing 15x103 and 6x103 cells/100 μl/well,
respectively. The cultured cells were then treated the same
(triplicate wells per condition) by the addition of 100 μl of
serial dilutions of the DP extract dissolved in DMSO to
give a final concentration of 30, 10 and 1 μg/ml. For PC-3,
the extract was added after 24 h of incubation. In addition,
the DMSO alone was added to another set of cells as the
solvent control (DMSO <0.1%). The cells were then incu-
bated for another 48 h prior to the addition of 20 μl of
2.5 mg/ml solution of 3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) into each well. The
incubation was continued for another 3 h before the media
was removed. A mixture of DMSO (150 μl) was added to
each well and mixed to ensure dissolving of the crystal
formazan before the absorbance at 570 nm was measured.
Three replications of each experiment were performed and
fifty percent of inhibitory concentration (IC50) of each ex-
tract was calculated.
DNA content and cell cycle phase distribution
HL-60 cells (1x106 cells/2 ml/well) were treated with DP
at 20, 50, 100 μg/ml for 24 h. They were harvested and
washed with 1 ml of PBS, then centrifuged 400 g for
5 min at 4°C. The pellet was suspended in 100 μl of PBS
and 900 μl of hypertonic buffer (PI-25 μg/ml, RNAase-40
μg/ml, sodium citrate-0.1% and Triton-100X-0.03%) and
incubated at 37°C in dark for 20 min. Finally, cells were
analyzed immediately on flow cytometer FACSCalibur
(Becton Dickinson, USA). The data were collected in list
mode on 10,000 events and illustrated in a histogram,
where the number of cells (counts) is plotted against the
relative fluorescence intensity of PI (FL-2; λem: 585 nm;
red fluorescence). The resulting DNA distributions were
analyzed by Modfit (Verity Software House Inc., Topsham,
ME) for the proportions of cells in G0-G1, S- phase, and
G2-M phases of the cell cycle [20].
Hoechst 33258 staining of cells for nuclear morphology
HL-60 cells (2x106 cells/3 ml/well) were treated with DP
extract at different concentration of extract for 24 h.
They were collected, centrifuged at 400 g and washed
once with PBS. A solution of Hoechst (Hoechst, 10 μg/ml;
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was added in each tube and kept in the dark at room
temperature for 30 min. The mixture was then washed
once with PBS and the pellet resuspended in 100 μl of
PBS/glycerol (1:1). The solution (10 μl) was poured into
the slide and observed for nuclear morphology alter-
ations under fluorescence microscope (Olympus X 70,
magnification 20 X).
Mitochondrial membrane potential (MMP) assay
HL-60 cells (1x106 cells/2 ml/well) were treated with
DP extract at different concentrations for 24 h. Thirty
minutes before the end of the experiment, the cell cul-
ture was treated with Rhodamine-123 (200nM) and
keep in the dark for 30 mn. Cells were then collected,
centrifuged (400 g; 4°C; 5 min), the pellet was washed
with 1 ml of PBS and centrifuged as mentioned earlier.
The fluorescence intensity of 10,000 events was ana-
lyzed in FL-1 channel on BD FACSCalibur (Becton
Dickinson, USA) flow cytometer. The decrease in fluor-
escence intensity because of mitochondrial membrane
potential loss was analyzed in FL-1 channel and the
change of in potential membrane (Δψm) was assessed
by comparing fluorescence.
Reactive oxygen species (ROS) assay
ROS production was monitored by flow cytometry using
2’, 7’-dichlorodihydrofluorescin diacetate (DCFH2-DA).
This dye is a stable non polar compound that readily
diffuses into cells and is hydrolyzed by intracellular es-
terase to yield 2’,7’-dichloro dihydrofluorescin (DCFH),
which is trapped within the cells. Hydrogen peroxide
or low molecular weight peroxides produced by the
cells oxidize DCFH to the highly fluorescent compound
2’,7’-dichlorofluorescein (DCF). Thus, the fluorescence
intensity is proportional to the amount of hydrogen per-
oxide produced by the cells. Briefly, HL-60 cells (1x106
cells/2 ml/well) were treated with DP at different con-
centration for 24 h. Thirty minutes before the end of
the experiment, the cell culture was treated with
DCFH2-DA (50 μM) and keep in the dark. Cells were
then collected, centrifuged (200 g; 4°C; 5 min) and the
pellet was washed with 1 ml of PBS and centrifuged as
mentioned earlier. The pellet was suspended in 500 μl
of PBS and the fluorescence was assessed by comparing
two fluorescence emission 480 nm/530 nm using a
flow-cytometer (BD-LSR).
Statistical analysis
The viability experiments were done in triplicates and
each data point represents the average of at least 3 in-
dependent experiments. The data was expressed as mean
± SD. In order to carry out statistical analysis, the data was
analyzed using SPSS (Version 11.5; SPSS Inc.,) and M.S.Office, Excel software. One way analysis of variance
technique was applied to observe the significance be-
tween the groups. The post hoc test Duncan’s multiple
range test was performed to know the significant diffe-
rence among the groups. Entire statistical analysis was
carried out at p < 0.05.
Results
In this study, the human promyelocytic leukemia cell
line, (HL-60), was used to investigate the capability of
the methanol extract of DP to induce apoptosis and
elaborate its molecular mechanism. After extraction, the
yield of DP extract was 26.6%.
Effects of DP extracts on the proliferation of HL-60 and
PC-3 cells
Using a conventional tatrazolium-based colorimetric cell
proliferation assay, we screened the antiproliferative
activity of DP at 100 μg/ml for 48 h. The results demon-
strated that these extracts reduced the cell viability be-
tween 6.25 and 6.87% depending on the cells. The
viability of both cells decrease from 60.4 ± 2.84% and
65.51 ± 6.70% respectively for HL-60 and PC-3 at 1 μg/ml
to 6.25 ± 2.31% and 6.87 ± 3.15% at 100 μg/ml after
treatment. Further, the cytotoxicity effects of this extract
were performed at different concentrations (1–100 μg/ml)
as shown in the Figure 1. After 48 h, the extract
of DP demonstrated a significant reduction of cell viability
on both cell lines in a dose dependent manner. The fifty
percent inhibitory concentrations (IC50) were 12 ±
1.54 μg/ml and 18 ± 0.49 μg/ml respectively with HL-60
and PC-3 (Table 1). This result confirmed that DP has sig-
nificant cytotoxicity property on HL-60 cells and this cell
line was chosen for the other experiments.
Morphological changes of apoptotic treated HL-60 cells
with DP extract
Nucleosomal DNA fragmentation is the result of acti-
vation of endogenous endonuclease. To investigate
whether the DP extract can induce apoptosis and nu-
clear modification on HL-60 cells after 24 h of treat-
ment, the Hoechst 33258 staining was also carried out
at different concentrations (20, 50 and 100 μg/ml). It is
a membrane-permeable blue fluorescent dye which
stained cell nucleus. The results show that the untreated
HL-60 cells present the uniformly light blue nuclei
under fluorescence microscope demonstrating that the
cells are in healthy conditions (Figure 2A). DP-treated
HL-60 cells exhibited a bright blue color (Figure 2)
confirming the dead of cells. DP-treated HL-60 cells
showed condensed and marked fragmented nuclei in a
time-dependent manner (Figures 2C & 2D). At 100 μg/ml,
most of the cells go through apoptosis; and the in-


















Concentration of extracts (µg/ml)
HL-60 PC-3
Figure 1 Viability of PC-3 and HL-60 cells after 48 h treatment with DP extract (n = 3).
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mentation of DNA of death HL-60 cells.
Reactive specific oxygen (ROS) production by treated
HL-60 cells with DP extract
ROS are generated in and around mitochondria and are
regarded as the byproducts of normal cellular oxidative
processes. As many anticancer drugs and DNA damage-
causing agents activate the apoptotic pathway through
ROS generation, the possibility that ROS elevation is a key
step in DP-induced apoptosis was assessed using DCFH2-
DA. The results showed that the intracellular ROS produc-
tion of treated HL-60 cells increased 7.54 and 9.32 folds
respectively at 20 and 50 μg/ml compare to the control
(Figure 3). However the ROS production at 100 μg/ml was
almost equal to the control the death of cells.
Effect of DP extract on the mitochondrial membrane
potential of HL-60 cells
Mitochondria play important role in the propagation of
apoptosis and they are responsible for 90% of the energy
needed for cells function. The disruption of mitochon-
drial integrity is one of the early events leading to apop-
tosis. To assess whether DP extract affects the function
of mitochondria, the potential changes in mitochondrial
membrane were analyzed by employing Rodamine-123,
a dye which indicates the loss of mitochondrial mem-
brane potential.Table 1 Cells viability and fifty percent inhibition of
HL-60 and PC-3 cells after 48 h
Cell lines Viability (%) IC50
100 μg/ml (μg/ml)
HL-60 6.25 ± 2.31 12 ± 1.5
PC-3 6.87 ± 3.15 18 ± 0.49
Results are represented as mean ± SD, n = 3.The results showed that the untreated HL-60 cells
retained 90.89% of fluorescence. After 24 h of treatment
cells with DP extract, the decline of fluorescence was en-
hanced in a concentration dependent manner from
23.03% at 20 μg/ml to 88.13% at 100 μg/ml (Figure 4).
This result confirmed that DP extract induced apoptosis
through the disruption of mitochondria membrane poten-
tial. This finding supports the view that alteration of mito-
chondria functions play a major role in the apoptosis in
particular in cell death induced by chemotherapy [21].
Effect of DP extract on DNA content and cell cycle of
HL-60 cells
The flow cytometric analysis of propiduim Iodide (PI)-
stained was used to investigate the effect of DP extract
on cell cycle progression on HL-60 cells. The results
showed that the normal distribution cell cycle in the
control. After treatment with extract at different concen-
tration, the accumulation of cells was found in apoptotic
phase (subG1) with significant modification of G2/M
and S phases at the concentration of 20 and 50 μg/ml
(Figure 5). Cells treated with 100 μg/ml of extract
resulted to extensive accumulation of subG1 phase and
loss of normal profile of the cell cycle.
The results demonstrated that DP extract induced apop-
tosis on HL-60 cells through cell cycle arrest. The propor-
tion of cells in subG1 and S phases increased whereas cells
in G1/Go phase decreased significantly in a concentration
dependent manner compare to the control (Figure 6). The
level of variation is between 2.87 - 107.43 and 2.52 -100.68
fold respectively for subG1 and G1/Go.
Discussion
Recently, important attention has been focused on identify-
ing natural substances capable of inhibiting or retarding the
process of different stages of carcinogenesis. Anticancer




Figure 2 Effect of DP extract on nuclear morphological changes of HL-60 cells after 24 h and observation under fluorescence
microscope (Olympus, Tokoy, Japan; magnification · 200). (A): control; (B): Camptotecin (2 μM); (C): 20 μg/ml; (D):
50 μg/ml; (E): 100 μg/ml.
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the cancer cells are the drugs of choice [22]. Finding novel
natural compounds with low toxicity and high selectiv-
ity of killing cancer cells is an important area in cancer
research. Anticancer drugs act by interfering with cell











Figure 3 Effects of extract DP on ROS production on HL-60 cells; Cell
DCHFH2-DA (5 μM), incubated for 30 min and the fluorescence in the
presented the fluorescence intensity: (A): control; (B): 20 μg/ml; (C): 50 μg/cell death, known as apoptosis [23]. Our studies re-
vealed that DP extract demonstrated cytotoxicity activ-
ity on HL-60 and PC-3 cell lines with IC50 of 12 and
18 μg/ml respectively. These values are lower than
20 μg/ml (Figure 1). According to the US NCI plant







s were treated with extract for 24 h followed by staining with
cells was immediately analyzed using flow cytometry. Data are










M1:   9.11± 1.5% 
M1: 88.06± 4.7%
D
M1  23.03±3.6 %
B
Figure 4 Effects of DP on the integrity of mitochondrial membrane of HL-60 cells after 24 h. Data are presented the fluorescence
intensity: (A): control; (B): 20 μg/ml; (C): 50 μg/ml; (D): 100 μg/ml.
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cubation between 48 and 72 h is less than 20 μg/ml
[24]. Previous studies have indicated that root extract of
DP has inhibitory activity against various cancer cell
lines [12]. Cytotoxicity of DP extract arises its ability to
interact with proteins, DNA via several functional
groups by ionic interaction [25] or by DNA interca-
lation [26]. Literatures data on the cytotoxicity and
apoptosis properties of DP extract are scarce. Our study
is the baseline study on cytotoxicity and the apoptosis
inducing properties of DP extracts on HL-60 cells.
Apoptosis provides a number of clues with respect to
effective anticancer therapy, and many chemotherapeu-
tic agents reportedly to exert their antitumor effects by
inducing apoptosis in cancer cells. Three apoptosis pa-
rameters of the intrinsic mediated apoptosis pathway
have been investigated in our study with the HL-60 cells
(i) apoptosis mediated by cell cycle arrest through the
fixation to the receptors ; (ii) apoptosis mediated by
mitochondria-involved signaling; (iii) the reactive oxy-
gen species (ROS) induced apoptosis.
Cell cycle arrest is one of main the targets of many anti-
cancer drugs such as camptothecin, doxorubicin, cisplatin,
5-fluorouracil. It has been shown that the ability of mole-
cules/drugs to arrest cell cycle in G2/M or S phase was
related to their sensitivity and increased with cell resist-
ance [27]. Our results showed the increase of apoptotic
cells, G2/M and M phase in a concentration dependent
manner when the concentration of extract was raised
compare with the control (Figure 6). This result showed
that extract could act at all the stages of HL-60 cell cycle
in a concentration-dependent and can be ranged amongthe cell cycle with non-specific agents. Several studies have
reported that apoptosis involves a disruption of mitochon-
drial membrane integrity is decisive for the cell death
process [28-30] and the depolarization of mitochondrial
membrane potential is a characteristic feature of apop-
tosis. The evaluation of the effects of DP extract on the
mitochondrial membrane potential (Δψm) demonstrated
the increase of loss of intensity of fluorescence respectively
2.52%; 5.62% and 9.66% fold at 20, 50 and 100 μg/ml. The
decline of the fluorescence confirmed the death of the
treated-HL-60 cells through the depolarization of their
mitochondrial membrane potential. The finding confirmed
that DP extract induces apoptosis of HL-60 through the
disruption of mitochondrial membrane potential. This re-
sult supports the concepts that mitochondria are one of
the most important organelles in cells which play crit-
ical roles in the mitochondrial apoptosis signal trans-
duction pathway [22]. The loss of membrane potential
is an early event in mitochondrial-mediated apoptosis
[31]. After the reduction of membrane potential and the
release of mitochondrial cytochrome C, a critical step is
the formation of apoptosomes.
Identification of some features characteristic of apop-
totic morphology such as degradation of DNA and apop-
totic bodies (Figures 2D & 2E) confirm the specific
cleavage of DNA at sites between nucleosomes and the for-
mation of a “ladder’ an indicator of apoptosis by DP extract
[32]. The relationships between the mitochondrial dysfunc-
tions observed during aging ROS production is still debated
[33]. A disruption of mitochondrial membrane potential
was observed in HL-60 cells exposed to oxidative stress




Figure 5 Cell cycle analysis of DP extract on HL-60 cells after 24 h. (A): Control; (B): 20 μg/ml; (C): 50 μg/ml; (D): 100 μg/ml. Data shown are
expressed mean ± SD, Values affected with different letter are significantly different in the group, (p < 0.05).
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production of ROS results in oxidative damage including
lipid peroxidation, protein oxidation and DNA damage. A
number of studies have shown that the phytochemicals in-
volved in ROS production can selectively kill the cancer






















Figure 6 Effect of DP extract on cell distribution after 24 h. Data repre
significantly different in comparison with the control.[30,36,37]. HL-60 treated cells increase ROS production
for almost 7.54 and 9.33 fold at 20 and 50 μg/ml respect-
ively. These results confirmed that ROS were crucial in
the induction of apoptosis and acted as upstream signaling
molecules to initiate cell death. Besides apoptosis, the re-







sents mean ± S.D. of three experiments. p < 0.001 was considered
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mitochondrial membrane potential and increased of ROS
production on HL-60 cells.
Identification of the phytochemicals compounds respon-
sible of apoptosis may have important on anticarcinogenic
activities [38]. Studies have been reported the presence
of several bioactives compounds in DP extracts such as
flavonoids, furano-coumarins, phenylated flavonoids
[16,17]. Several studies demonstrated the mechanistic
induction of apoptosis of different main groups of com-
pounds present in DP extracts such as phenylated flavo-
noids [39,40] benzofuran [41]. Reports showed that
plant-derived phenylated flavonoids and benzofuran, are
cytostatic against various human cancer cell lines and
induces apoptosis [42]. Therefore, our data suggested the
possibility that DP might penetrate into cells and directly
target mitochondria to increase membrane permeability
and decrease (Δψm) accompanied by ROS production.
Conclusion
The present study indicates that DP extract can effect-
ively inhibit proliferation of HL-60 and PC-3 cells. The
apoptosis induction of HL-60 cells is accompanied by




PI: Propidium iodide; Rh-123: Rhodamine- 123; DCFH2-DA: 2’, 7’-
dichlorodihydrofluorescin diacetate.
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